SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001096906-22-002338
Filing Date
2022-09-23
Accepted
2022-09-23 16:35:32
Documents
1
Period of Report
2022-09-23

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form3.html 3  
1 PRIMARY DOCUMENT form3.xml 3 3011
  Complete submission text file 0001096906-22-002338.txt   4533
Mailing Address 6191 CORNERSTONE COURT, E SUITE 114 SAN DIEGO CA 92121
Business Address 6191 CORNERSTONE COURT, E SUITE 114 SAN DIEGO CA 92121 (212) 751-0001
AXIM BIOTECHNOLOGIES, INC. (Issuer) CIK: 0001514946 (see all company filings)

IRS No.: 274092986 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NORTHVIEW ACQUISITION CORP. 207 WEST 25TH STREET, 9TH FLOOR NEW YORK NY 10001
Business Address
O'Rourke Peter (Reporting) CIK: 0001890749 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-54296 | Film No.: 221262723